Growth continues for another quarter as market leaders gain more share.

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY.

Among the many topics covered in the Q318 Infection Prevention Market Recap are:

The US market for Hemostats and Sealants accelerated substantially in Q318 vs Q218

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...

Among the many topics covered in the Q318 US Hemostats and Sealants Market Recap are:

The Spine hardware market appears to be stabilizing.

SmartTRAK reports that results from a recent Leerink MEDACorp survey suggest that the US Spine market may be turning the corner, with hospital administrators reporting slightly improved case volume growth of 0.9% for Q318 vs 0.7% for Q2. This is consistent with Leerink’s intra-quarter checks and conversations at the North American Spine Society (NASS) 2018 Annual Meeting that the market...

Among the many topics covered in the Q318 Spine Market Recap are:

BioMedGPS is proud to feature the top 2018 news and analysis from SmartTRAK’s team of domain experts in the orthopedics, wound care, and neuro therapies markets.

IRVINE, CA (PRWEB) JANUARY 02, 2019

SmartTRAK was cited as a source in a press release from Smith & Nephew entitled "Smith & Nephew expands opportunity in meniscal repair through acquisition of unique and highly complementary technology."

We covered a lot of ground in 2018. Everything from breaking medical device event coverage to interviews with some of the industry's top thought leaders.  We wrote and you read.  Here are the Top Blog Posts of 2018 that garnered the most attention from you and your colleagues.

As a reminder, if you'd like to stay on top of hot trends and technologies in the ortho, wound and neuro markets, make sure to sign up to receive a weekly summary of our latest blog posts.

Without further ado, SmartTRAK's 12 Top Blog Posts of the past year (not just 10, because at SmartTRAK, we always deliver more than expected) 

Acquisitions and Partnerships are Highpoints in Q318

SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...

Among the many topics covered in the Q318 OrthoBio Market Recap are:

All segments showing softness, lowest quarterly growth rate since 2015

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +3.0% YoY, with Acelity, also known as KCI, maintaining its leadership position with estimated Q318 revenues of...

SmartTRAK was excited to attend the 2018 Orthopaedic Summit (OSET), on December 5-8 at the Bellagio in Las Vegas, Nevada. And, our very own Kristina Meyer, Senior Analyst, Sports Medicine, landed on the front of the OSET banners. We always knew Kristina was a pretty big deal!  Thanks OSET for the coverage.

Pricing pressure continues to dampen the US Joint Fluid market, which experienced a double-digit decline of -9.9% according to SmartTRAK's Financial Dashboard results. While the market continues to expand in terms of the number of patients treated, ASPs have steadily eroded over the past three quarters since the Anthem non-coverage decision kicked in earlier this year. Year-to-date, the US Joint Fluid market slowed significantly, posting negative growth according to SmartTRAK estimates...